BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2006
View Archived Issues
Low blood and tumor tissue levels of tasquinimod sufficient for antiangiogenic actions
Read More
M.D. Anderson and Baylor team up in asthma and allergic diseases
Read More
Preclinical and clinical antiplatelet efficacy of pasugrel demonstrated
Read More
Sativex and placebo show similar significant efficacy in patients with painful diabetic neuropathy
Read More
Safety and efficacy of SB-509 demonstrated in a phase I trial in patients with diabetic neuropathy
Read More
SGLT-2 inhibitor AVE-2268 effectively lowers blood glucose and urinary glucose excretion in rodents
Read More
KW-3902 improves diuresis and renal function in patients with heart failure and renal impairment
Read More
Analgesic properties of the anticancer agent BIM-46187
Read More
Analgesic potential for PAR4 agonists
Read More
Santen patents novel strategy for allergic conjunctivitis
Read More
Recent patents impart new therapeutic agents for cancer
Read More
Recent patents divulge novel analgesic agents
Read More
Serono and Syntonix establish agreement to develop uniquely delivered FSH infertility treatment
Read More
Phase II trial under way with ASF-1096 for discoid lupus erythematosus
Read More
Cell Therapeutics establishes global alliance with Novartis for Xyotax
Read More
Clavis Pharma and Mount Sinai School of Medicine to collaborate on anticancer drugs
Read More
ArmaGen receives grant to develop first nerve gas antidote
Read More
Schering AG grants Bausch & Lomb license to SEGRA for ophthalmic use
Read More
Pfizer and Trans Tech Pharma to develop RAGE products for Alzheimer's disease
Read More
Milestone payment to AnorMED for Fosrenol approval in Germany
Read More
E.U. orphan medicinal product designation assigned to Nektar's amphotericin B inhalation powder
Read More
Opexa Therapeutics provides update on preclinical and clinical progress
Read More
ExonHit Therapeutics and Allergan strengthen strategic alliance
Read More
Organon and Schering AG to discontinue codevelopment of male hormonal contraceptive
Read More
Aastrom Biosciences reports promising interim data for Tissue Repair Cells
Read More
The VEGF antagonist bevacizumab shows promise in HHT: News in Context
Read More
Selective norepinephrine reuptake inhibitors developed by Wyeth
Read More
Connetics' Verdeso Foam approved for atopic dermatitis indication in U.S.
Read More
GlaxoSmithKline seeks FDA approval for Tykerb for advanced breast cancer
Read More